Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lakshmi Nayak, M.B.,B.S.

Concepts (265)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Central Nervous System Neoplasms2020238953.690 Why?
Lymphoma11202318772.120 Why?
Brain Neoplasms34202488631.810 Why?
Neoplasm Recurrence, Local24202392391.530 Why?
Glioblastoma21202434811.510 Why?
Lymphoma, Non-Hodgkin5202213811.210 Why?
Dacarbazine620175661.120 Why?
Paraneoplastic Syndromes220221511.050 Why?
Glioma11202034010.990 Why?
Salvage Therapy9201912750.960 Why?
Antineoplastic Agents, Alkylating420206270.950 Why?
Methotrexate6202217270.880 Why?
Antimetabolites, Antineoplastic420156400.830 Why?
Meningeal Carcinomatosis32020650.770 Why?
Erdheim-Chester Disease12020110.760 Why?
Meningioma6202212090.720 Why?
Meningeal Neoplasms6202212410.700 Why?
Combined Modality Therapy13202386420.700 Why?
Lymphoma, Large B-Cell, Diffuse4202313780.640 Why?
Antineoplastic Combined Chemotherapy Protocols142023115240.610 Why?
Lymphoma, T-Cell220192990.600 Why?
Antineoplastic Agents132019136950.570 Why?
Nervous System Diseases2202216220.550 Why?
Epothilones12015440.530 Why?
Dexamethasone1202219510.500 Why?
Angiogenesis Inhibitors6201920380.490 Why?
Immunocompromised Host120198470.470 Why?
Receptors, Vascular Endothelial Growth Factor120176640.450 Why?
Immunomagnetic Separation12013800.450 Why?
Stem Cell Transplantation3202216200.440 Why?
Lymphoma, B-Cell220179310.440 Why?
Astrocytoma220157900.430 Why?
Hematopoietic Stem Cell Transplantation4202354420.380 Why?
Testicular Neoplasms120178040.370 Why?
Vascular Endothelial Growth Factor A3201935080.360 Why?
Neoplastic Cells, Circulating320199340.330 Why?
Central Nervous System5202313570.320 Why?
Recombinant Fusion Proteins1201737720.310 Why?
Tumor Necrosis Factor-alpha1201944200.310 Why?
Dura Mater120092910.290 Why?
Prognosis192020290630.290 Why?
Neoplasms42022216830.280 Why?
Aged4020231632800.270 Why?
Aminopyridines320195420.260 Why?
Transplantation, Autologous5202321240.260 Why?
Humans7920247443430.250 Why?
Treatment Outcome222023631140.250 Why?
Antibodies, Monoclonal2202292740.240 Why?
Hematologic Neoplasms1201518320.220 Why?
Cytodiagnosis220194350.220 Why?
Radiotherapy4201915330.210 Why?
Survival Rate102020127880.200 Why?
Adult3820242140550.200 Why?
Middle Aged3720222133830.200 Why?
Autoimmunity1200913490.190 Why?
Lymphoma, Mantle-Cell120232330.190 Why?
Lung Neoplasms52020131020.190 Why?
Male4320203501180.180 Why?
Ki-67 Antigen120226440.180 Why?
Oligodendroglioma220132790.180 Why?
Oncolytic Viruses120233270.170 Why?
Neurotoxicity Syndromes120232900.170 Why?
Vincristine2201910390.170 Why?
Carcinoma, Non-Small-Cell Lung2201552210.170 Why?
Carcinoma, Adenosquamous12019680.170 Why?
Morpholines220195710.170 Why?
Radiotherapy, Adjuvant2201417700.160 Why?
Female4220203801940.160 Why?
Aged, 80 and over192020577760.160 Why?
Cyclophosphamide3201922420.160 Why?
Drug Administration Schedule3201549330.160 Why?
Phosphatidylinositol 3-Kinase120191300.160 Why?
Waldenstrom Macroglobulinemia2201810520.160 Why?
Herpesvirus 1, Human120237430.160 Why?
Oncolytic Virotherapy120234980.160 Why?
Cranial Irradiation120204010.150 Why?
Pyridazines120192020.150 Why?
Medical Oncology2202022650.150 Why?
Disease-Free Survival7202068950.140 Why?
Indoles2201518390.140 Why?
Nerve Tissue Proteins1200944620.130 Why?
Retrospective Studies182023774490.130 Why?
Follow-Up Studies112020390500.130 Why?
Blood-Brain Barrier2201910170.130 Why?
Nervous System Neoplasms12015910.130 Why?
Thiotepa32023660.130 Why?
Disease Progression92020132840.130 Why?
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor120151100.130 Why?
Small Cell Lung Carcinoma120193880.120 Why?
Immunotherapy, Adoptive2202312700.120 Why?
Drug Monitoring120209560.120 Why?
Receptors, Antigen, T-Cell2202325400.120 Why?
Chemotherapy, Adjuvant3201934790.120 Why?
Clinical Trials, Phase I as Topic120153230.120 Why?
Immunotherapy3201944450.120 Why?
Receptors, CXCR4120187260.110 Why?
Imidazoles1201912060.110 Why?
Survival Analysis52023102520.110 Why?
Protein Kinase Inhibitors2201955350.110 Why?
Antibodies, Monoclonal, Murine-Derived220146930.110 Why?
Prospective Studies52023532880.110 Why?
Neoplasm Staging62019110310.110 Why?
Guanine120132740.100 Why?
Glutamates120133980.100 Why?
Hydroxamic Acids120154940.100 Why?
Carcinoma, Ductal, Breast1201911010.100 Why?
Neoplasm Metastasis2202048510.100 Why?
Karnofsky Performance Status320191730.100 Why?
Pyrazoles2201919720.100 Why?
Fatigue2201615310.100 Why?
Transplantation Conditioning2201715980.100 Why?
Melanoma2202355100.090 Why?
Young Adult122019564300.090 Why?
Pyrimidines2201929420.090 Why?
Pilot Projects4201983240.090 Why?
Molecular Targeted Therapy3202027270.090 Why?
Neurology120187630.090 Why?
Benzhydryl Compounds120168450.090 Why?
DNA Copy Number Variations2201519410.090 Why?
Drug Resistance, Neoplasm4201951720.090 Why?
Immunologic Factors1201915800.090 Why?
Drug Therapy, Combination2201764890.090 Why?
Incidence32019209470.080 Why?
Dose-Response Relationship, Drug32020109430.080 Why?
Pyrroles1201511460.080 Why?
Kaplan-Meier Estimate5201865380.080 Why?
Radiotherapy Dosage1201528790.080 Why?
Cohort Studies82022405610.080 Why?
Neoadjuvant Therapy1201927280.080 Why?
Mutation42024297860.080 Why?
Diagnosis, Differential22015129590.080 Why?
Magnetic Resonance Imaging42020354210.070 Why?
Leukemia1201515110.070 Why?
Retreatment220196100.070 Why?
Recurrence2201983400.060 Why?
Tissue Plasminogen Activator1201112610.060 Why?
Busulfan220172630.060 Why?
Carmustine220141370.060 Why?
Lomustine22014590.060 Why?
Cytarabine220176920.060 Why?
Neuropsychological Tests1201769930.060 Why?
Comparative Genomic Hybridization220154960.060 Why?
Adenine220199360.060 Why?
Tomography, X-Ray Computed32022201290.060 Why?
Ovarian Neoplasms1202048380.060 Why?
Fibrinolytic Agents1201121580.050 Why?
Breast Neoplasms32020208220.050 Why?
Syndrome2201832510.050 Why?
Antigens, CD19120233800.050 Why?
Remission Induction2201723860.050 Why?
Piperidines2201916020.050 Why?
Inflammation12020106380.050 Why?
T-Lymphocytes32023101800.050 Why?
Tumor Burden2201519150.040 Why?
Palliative Care1201434930.040 Why?
Propensity Score2201717810.040 Why?
Research Design1201559870.040 Why?
Pathology, Molecular120223260.040 Why?
Receptor, TIE-2120191780.040 Why?
Random Allocation1202324290.040 Why?
DNA Helicases120248590.040 Why?
Age Factors42019183700.040 Why?
Algorithms22015138810.040 Why?
Maximum Tolerated Dose120208920.040 Why?
Microsatellite Repeats120208020.040 Why?
Benzylamines120182230.040 Why?
Seizures2202428590.040 Why?
Adolescent62019857810.040 Why?
Nausea120206730.040 Why?
Heterocyclic Compounds120182490.040 Why?
Proportional Hazards Models32017123540.040 Why?
Vomiting120206360.040 Why?
Hepatocyte Growth Factor120182700.040 Why?
DNA Mismatch Repair120204260.040 Why?
Burkitt Lymphoma120193270.040 Why?
Quality of Life22019128040.040 Why?
Vascular Endothelial Growth Factor Receptor-2120195460.040 Why?
Vascular Endothelial Growth Factor Receptor-1120195520.030 Why?
Tumor Escape120193490.030 Why?
Mucositis120171010.030 Why?
Mutagenesis1202012660.030 Why?
Genome-Wide Association Study12015122610.030 Why?
Drug Therapy120194970.030 Why?
Hospitalization12015102620.030 Why?
Toll-Like Receptors120195920.030 Why?
Bayes Theorem1202323090.030 Why?
Child32015777090.030 Why?
Proto-Oncogene Proteins c-met120185780.030 Why?
Thalidomide120198900.030 Why?
Genetic Markers1202026340.030 Why?
Procarbazine120131810.030 Why?
Fluorodeoxyglucose F181202220160.030 Why?
Selection Bias120153710.030 Why?
Gene Frequency1202035880.030 Why?
Clinical Trials, Phase II as Topic120156290.030 Why?
Enzyme Activation1201937010.030 Why?
Cell Cycle Proteins1202434620.030 Why?
Immunoenzyme Techniques1201517990.030 Why?
Xenograft Model Antitumor Assays1202035570.030 Why?
Evidence-Based Medicine2201436100.030 Why?
Interdisciplinary Communication120189500.030 Why?
Absorbable Implants120143420.030 Why?
Brain22023263850.020 Why?
Hyperglycemia1202013730.020 Why?
Tumor Microenvironment1202335860.020 Why?
International Cooperation1201814200.020 Why?
Tissue Distribution1201523270.020 Why?
Cooperative Behavior1201815040.020 Why?
Neoplasm, Residual120159730.020 Why?
Endothelial Cells1202334790.020 Why?
SEER Program1201515080.020 Why?
High-Throughput Nucleotide Sequencing1202235970.020 Why?
TOR Serine-Threonine Kinases1201921090.020 Why?
Histone Deacetylase Inhibitors120157890.020 Why?
Infusions, Intravenous1201422740.020 Why?
Isocitrate Dehydrogenase120158710.020 Why?
Observer Variation1201525930.020 Why?
Phosphatidylinositol 3-Kinases1201929380.020 Why?
PTEN Phosphohydrolase1201511420.020 Why?
Stroke1201199810.020 Why?
Nuclear Proteins1202458530.020 Why?
Clinical Trials, Phase III as Topic120138410.020 Why?
Sequence Analysis, DNA1202048030.020 Why?
Bacterial Infections1201714010.020 Why?
Disease Management1201924590.020 Why?
Genomics1202457200.020 Why?
Administration, Oral1201539130.020 Why?
Randomized Controlled Trials as Topic2201599590.020 Why?
Cost-Benefit Analysis1202053910.020 Why?
Genetic Testing1202034440.020 Why?
Receptor Protein-Tyrosine Kinases1201416600.020 Why?
Genome, Human1202044200.020 Why?
Time Factors22019400750.020 Why?
Clinical Trials as Topic1202279130.020 Why?
Adrenal Cortex Hormones1201418550.020 Why?
Reproducibility of Results12023199050.020 Why?
Early Detection of Cancer1201930860.020 Why?
Anticonvulsants1201419160.020 Why?
Tumor Suppressor Protein p531201529480.020 Why?
Cytokines1201973220.020 Why?
Neurosurgical Procedures1201520020.020 Why?
Sensitivity and Specificity12019147220.010 Why?
Transcription Factors12024122080.010 Why?
Risk Factors32015722900.010 Why?
Patient Selection1201542150.010 Why?
Image Processing, Computer-Assisted1202089490.010 Why?
Mass Screening1201952550.010 Why?
Drug Delivery Systems1201422190.010 Why?
Phenotype12020163650.010 Why?
Gene Expression Regulation, Neoplastic1201884280.010 Why?
Venous Thromboembolism1201416710.010 Why?
Double-Blind Method12016120260.010 Why?
Massachusetts1201486630.010 Why?
Multivariate Analysis12015122450.010 Why?
Genotype12015129510.010 Why?
Databases, Factual1201577290.010 Why?
Hemorrhage1201134610.010 Why?
Gene Expression Profiling1201594380.010 Why?
Practice Guidelines as Topic1201572790.010 Why?
Signal Transduction12018234030.010 Why?
Risk Assessment12015233380.010 Why?
Infant12015351360.010 Why?
Mice12020811830.010 Why?
Child, Preschool12015410060.010 Why?
Animals120201687570.000 Why?
Nayak's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (265)
Explore
_
Co-Authors (123)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.